Christoph Kettelhack
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christoph Kettelhack has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Christoph Koella
Department of General and Vascular Surgery Kantonsspital Bruderholz 4101 Bruderholz Basel Switzerland
1 shared publicationDaniel Oertli
Department of General Surgery University Hospital Basel Spitalstrasse 21 4031 Basel Switzerland
1 shared publicationLorenz Gurke
University Centre for Vascular Surgery Aarau/Basel, Spitalstrasse 21 4031 Basel Switzerland
1 shared publicationPeter Stierli
University Centre for Vascular Surgery Aarau/Basel, Spitalstrasse 21 4031 Basel Switzerland
1 shared publicationPhilipp Fueglistaler
University Centre for Vascular Surgery, Aarau/Basel, and Department of General Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland
1 shared publicationTamim Obeid
University Centre for Vascular Surgery Aarau/Basel, Spitalstrasse 21 4031 Basel Switzerland
1 shared publication
Latest Publications
- 5 February 2009
- Published by Springer Nature in Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
- Vol. 23 (1) , 50-54
Die isolierte Extremitätenperfusion bei regional metastasierendem Melanom und fortgeschrittenen Weichgewebssarkomen
- 5 February 2009
- Published by Springer Nature in Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
- Vol. 23 (1) , 50-54
Die isolierte Extremitätenperfusion bei regional metastasierendem Melanom und fortgeschrittenen Weichgewebssarkomen
- 13 June 2006
- Published by Wiley in World Journal of Surgery
- Vol. 30 (7) , 1344-1349
Major Vascular Resection and Prosthetic Replacement for Retroperitoneal Tumors
Introduction: Involvement of major vascular structures has been considered a limiting factor for resecting advanced tumors. The objective of this study was to evaluate the outcome after concomitant retroperitoneal tumor and vascular resection with prosthetic replacement of the aorta/vena cava.Methods: The authors reviewed a 5‐year series of eight patients with a median age of 50 years (range 11–68 years) who had undergone resection of a retroperitoneal tumor and concomitant resection and replacement of the abdominal aorta, inferior vena cava, or both. The histologic diagnoses were sarcoma (five patients), teratoma (one), transitional cell carcinoma (one), and ganglioneuroma (one). The main outcome measures were early (< 30 days) and late (≥ 30 days) surgical morbidity and mortality. Secondary endpoints were vascular graft patency and tumor‐free survival. Two patients underwent combined graft replacement of the aorta and vena cava. Single aortic and vena cava graft replacement were each done in three patients.Results: Two patients showed early surgical morbidity necessitating reoperation for a thrombotic graft occlusion. No patient died during the early course of the follow‐up. During a median follow‐up of 14 months (range 1–56 months), two patients had late surgical morbidity. The median tumor‐free survival for patients with malignancy was 14 months (range 1–54 months). One patient developed locoregional tumor recurrence, and two developed distant metastases. The median survival for patients with malignancy was 14 months (range 1–60 months).Conclusions: An aggressive surgical approach for otherwise unresectable retroperitoneal tumors with vascular resection and prosthetic vascular replacement is justified in selected cases and has acceptable morbidity and mortality.
- 13 June 2006
- Published by Wiley in World Journal of Surgery
- Vol. 30 (7) , 1344-1349
Major Vascular Resection and Prosthetic Replacement for Retroperitoneal Tumors
Introduction: Involvement of major vascular structures has been considered a limiting factor for resecting advanced tumors. The objective of this study was to evaluate the outcome after concomitant retroperitoneal tumor and vascular resection with prosthetic replacement of the aorta/vena cava.Methods: The authors reviewed a 5‐year series of eight patients with a median age of 50 years (range 11–68 years) who had undergone resection of a retroperitoneal tumor and concomitant resection and replacement of the abdominal aorta, inferior vena cava, or both. The histologic diagnoses were sarcoma (five patients), teratoma (one), transitional cell carcinoma (one), and ganglioneuroma (one). The main outcome measures were early (< 30 days) and late (≥ 30 days) surgical morbidity and mortality. Secondary endpoints were vascular graft patency and tumor‐free survival. Two patients underwent combined graft replacement of the aorta and vena cava. Single aortic and vena cava graft replacement were each done in three patients.Results: Two patients showed early surgical morbidity necessitating reoperation for a thrombotic graft occlusion. No patient died during the early course of the follow‐up. During a median follow‐up of 14 months (range 1–56 months), two patients had late surgical morbidity. The median tumor‐free survival for patients with malignancy was 14 months (range 1–54 months). One patient developed locoregional tumor recurrence, and two developed distant metastases. The median survival for patients with malignancy was 14 months (range 1–60 months).Conclusions: An aggressive surgical approach for otherwise unresectable retroperitoneal tumors with vascular resection and prosthetic vascular replacement is justified in selected cases and has acceptable morbidity and mortality.